ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 57199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 57199; 2) Community: the network communities that were significantly associated with the response to NSC 57199; 3) Molecule: the relationships between components within communities and NSC 57199; 4) MDR: the compounds that were significantly associated with the NSC 57199.

NSC Compound Enrichment Correlation
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.0284045326811618 0.70263196
NSC 674106 2-Acetylimidazo[4,5-b]pyridin 4 tolyl 3 thiosemicarbazone 0.0284045326811618 0.30430598
NSC 676372 Null 0.0284045326811618 0.036717478
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0284045326811618 0.26478699
NSC 683558 Camptothecin Derivative 0.0284045326811618 0.70351562
NSC 690270 ANTINEOPLASTIC-690270 0.0284045326811618 0.49394371
NSC 691127 Null 0.0284045326811618 0.32858798
NSC 695941 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate 0.0284045326811618 0.31777475
NSC 696558 N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid 0.0284045326811618 0.44561709
NSC 697653 Null 0.0284045326811618 0.47338561
Total:66  Current:38    [First] [Prev] [Next] [Last]